Deutetrabenazine, also known as SD-809 and Tetrabenazine-d6, is an investigational, oral, small-molecule inhibitor of vesicular monoamine 2 transporter, or VMAT2, that is designed to regulate the levels of a specific neurotransmitter, dopamine, in the brain. Deutetrabenazine is a deuterated tetrabenazine. SD-809 is being developed for the treatment of chorea associated with Huntington’s disease, a neurodegenerative movement disorder that impacts cognition, behavior, and movements. Teva is investigating the broad potential of SD-809 for treating additional movements disorders such as tardive dyskinesia and tics associated with Tourette syndrome.
Reference: Chandra Ray, Purna & Dadaji Pawar, Yogesh & Tukaram Singare, Dnyaneshwar & Nandkumar Deshpande, Tushar & Pal Singh, Girij. (2018). Novel Process for Preparation of Tetrabenazine and Deutetrabenazine. Organic Process Research & Development. 22. 10.1021/acs.oprd.8b00011.
Chandra Ray, Purna & Dadaji Pawar, Yogesh & Tukaram Singare, Dnyaneshwar & Nandkumar Deshpande, Tushar & Pal Singh, Girij. (2018). Novel Process for Preparation of Tetrabenazine and Deutetrabenazine. Organic Process Research & Development. 22. 10.1021/acs.oprd.8b00011.
Reference: Shah, Pratik; Saks, Samuel. Benzoquinolines as inhibitors of vesicular monoamine transporter 2 and their preparation. WO 2015077521. (Assignee Auspex Pharmaceuticals, Inc., USA)
Shah, Pratik; Saks, Samuel. Benzoquinolines as inhibitors of vesicular monoamine transporter 2 and their preparation. WO 2015077521. (Assignee Auspex Pharmaceuticals, Inc., USA)
Reference: Zhang, Chengzhi. Methods of manufacturing benzoquinoline compounds as inhibitors of vesicular monoamine transporter 2 (VMAT2). US 20150152099. (Assignee Auspex Pharmaceuticals, Inc., USA)
Zhang, Chengzhi. Methods of manufacturing benzoquinoline compounds as inhibitors of vesicular monoamine transporter 2 (VMAT2). US 20150152099. (Assignee Auspex Pharmaceuticals, Inc., USA)
Reference: Despande, Tushar Nandkumar; Singare, Dnyaneshwar Tukaram; Pawar, Yogesh Dadaji; Chavan, Yuvraj Atmaram; Ray, Purna Chandra; Singh, Girij Pal. Novel process for the preparation of tetrabenazine and deutetrabenazine. WO 2017182916. (Assignee Lupin Limited, India)
Despande, Tushar Nandkumar; Singare, Dnyaneshwar Tukaram; Pawar, Yogesh Dadaji; Chavan, Yuvraj Atmaram; Ray, Purna Chandra; Singh, Girij Pal. Novel process for the preparation of tetrabenazine and deutetrabenazine. WO 2017182916. (Assignee Lupin Limited, India)
Reference: Shah, Pratik. Preparation of benzoquinolines as for treatment of abnormal muscular activity. WO 2015077520. (Assignee Auspex Pharmaceuticals, Inc., USA)
Shah, Pratik. Preparation of benzoquinolines as for treatment of abnormal muscular activity. WO 2015077520. (Assignee Auspex Pharmaceuticals, Inc., USA)
Reference: Zhang, Chengzi; Kerr, Jim. Analogs of deutetrabenazine, their preparation and use. WO 2018170214.
Zhang, Chengzi; Kerr, Jim. Analogs of deutetrabenazine, their preparation and use. WO 2018170214.
Jayachandra, Sureshbabu; Srinivasarao, Attanti Veera Venkata; Rathinapandian, Jabaraj; Chandupatla, Shivakumar; Kommaraju, Srinivas. Methods and intermediates for preparing deutetrabenazine. Assignee Mylan Laboratories Ltd., India.IN 201741047280. 2019.
Alaparthi, Lakshmi Prasad; Sharma, Uday; Reddy, Gangireddy Kamalakar. A novel process for preparation of deutetrabenazine. WO 2019150387. 2019.
